Novo Nordisk A/S Common Stock (NVO)
Total Costs & Expenses
kr 187.33B
TTM · Period ending: · DKK
NVO Total Costs & Expenses
Latest reportedkr 187.33B DKKperiod ending
Latest reportedkr 187.33B DKKperiod ending
NVO TTM Total Costs & Expenses · DKK (kr 4.19B → kr 187.33B)
TTM Total Costs & Expenses
High-resolution chart · PNG
NVO total costs & expenses history
Trailing twelve months (TTM) · DKK. Each value covers four complete reported quarters.
| Period ending | Total Costs & Expenses (DKK) |
|---|---|
| 28,602,601,000 | |
| 29,341,738,000 | |
| 29,558,274,000 | |
| 32,954,900,000 | |
| 23,433,468,000 | |
| 21,971,230,000 | |
| 21,039,603,000 | |
| 20,352,203,000 | |
| 19,563,797,000 | |
| 19,109,313,000 | |
| 18,670,702,000 | |
| 18,483,111,000 | |
| 17,764,188,000 | |
| 17,320,779,000 | |
| 16,755,246,000 | |
| 16,269,038,000 | |
| 15,622,231,000 | |
| 15,005,118,000 | |
| 14,812,720,000 | |
| 14,022,253,000 | |
| 13,571,179,000 | |
| 13,636,912,000 | |
| 13,572,795,000 | |
| 13,719,057,000 | |
| 13,876,051,000 | |
| 13,725,764,000 | |
| 13,466,468,000 | |
| 14,150,675,000 | |
| 13,906,888,000 | |
| 13,487,374,000 | |
| 13,002,278,000 | |
| 11,475,069,000 | |
| 10,909,562,000 | |
| 10,715,290,000 | |
| 10,750,844,000 | |
| 10,981,122,000 | |
| 10,808,314,000 | |
| 10,248,041,000 | |
| 9,862,587,000 | |
| 9,244,082,000 | |
| 8,880,685,000 | |
| 8,663,364,000 | |
| 8,327,504,000 | |
| 8,146,423,000 | |
| 7,864,767,000 | |
| 7,590,252,000 | |
| 7,625,534,000 | |
| 7,116,543,000 | |
| 6,689,026,000 | |
| 6,318,984,000 | |
| 5,530,599,000 | |
| 5,278,271,000 | |
| 5,229,238,000 | |
| 5,009,676,000 | |
| 5,050,132,000 | |
| 4,710,930,000 | |
| 4,454,272,000 | |
| 4,396,720,000 | |
| 4,194,431,000 | |
| 4,191,465,000 | |
| 4,162,734,500 |